Abstract
Understanding how the immune system evolves across the human lifespan and responds to acute perturbations such as infection is critical for designing effective vaccines and therapies for age-related diseases. Here we profiled immune responses to SARS-CoV-2 vaccination and infection across 1,000 individuals spanning ages 25-96 using multi-omic platforms including mass cytometry, transcriptomics, and proteomics, revealing age-associated immune remodeling patterns that predict vaccine responsiveness.